Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Options Exercise | $6.81M | +109K | $62.21 | 109K | May 10, 2021 | Direct | ||
transaction | CVS | Common Stock | Sale | -$9.41M | -109K | -100% | $86.00 | 0 | May 10, 2021 | Direct | F1 |
holding | CVS | Common Stock | 81.2K | May 10, 2021 | By GRAT | ||||||
holding | CVS | Common Stock (restricted) | 8.01K | May 10, 2021 | Direct | ||||||
holding | CVS | Stock Unit | 45.7K | May 10, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Stock Option | Options Exercise | $0 | -109K | -75% | $0.00 | 36.5K | May 10, 2021 | Common Stock | 109K | $62.21 | Direct | F2 |
holding | CVS | Stock Option | 51.4K | May 10, 2021 | Common Stock | 51.4K | $102.26 | Direct | F3 | |||||
holding | CVS | Stock Option | 71.7K | May 10, 2021 | Common Stock | 71.7K | $104.82 | Direct | F4 | |||||
holding | CVS | Stock Option | 125K | May 10, 2021 | Common Stock | 125K | $78.05 | Direct | F5 | |||||
holding | CVS | Stock Option | 101K | May 10, 2021 | Common Stock | 101K | $54.19 | Direct | F6 | |||||
holding | CVS | Stock Option | 148K | May 10, 2021 | Common Stock | 148K | $58.34 | Direct | F7, F8 | |||||
holding | CVS | Stock Option | 155K | May 10, 2021 | Common Stock | 155K | $74.30 | Direct | F9 |
Id | Content |
---|---|
F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F2 | Option became exercisable in four equal annual installments, commencing 4/1/2019. |
F3 | Option became exercisable in four equal annual installments, commencing 4/1/2016. |
F4 | Option became exercisable in four equal annual installments, commencing 4/1/2017. |
F5 | Option became exercisable in four equal annual installments, commencing 4/3/2018. |
F6 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
F7 | The number of shares subject to the option were calculated using a 30-day average price. |
F8 | Option became exercisable in four equal annual installments, commencing 4/1/2021. |
F9 | Option becomes exercisable in four equal installments, commencing 4/1/2022. |